Misaki Ishibane   Hirofumi Hashimoto   Meika Kaneko   Shota Saito   Sangjon Pae   Shinpei Saito   Yoshie Reien   Yuri Hirayama   Nobuyo Higashi-Kuwata   Hiroaki Mitsuya   Naohiko Anzai   
Journal of pharmacological sciences 150(4) 201-203 2022年12月
Currently, the emergence of drug resistance is an important issue in the treatment of hepatitis B virus (HBV). Recently, our collaborating group developed a novel long-acting anti-HBV drug, E-CFCP. However, until this study, the effects of E-CFCP ...